EUVIMEDEUVIMED entdecken
Fall-Kontroll-StudieOpen Access · CC BY 4.0

A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2

Maria Zanti, Denise G O'Mahony, Michael T Parsons, Hongyan Li, Joe Dennis, Kristiina Aittomäkkiki, Irene L Andrulis, Hoda Anton-Culver, Kristan J Aronson, Annelie Augustinsson, Heiko Becher, Stig E Bojesen und 48 weitere

Human Mutation · 2023

DOI: 10.1155/2023/9961341 ↗

Kurz gefasst

Fall-Kontroll-Studie in der Zeitschrift Human Mutation, 2023. Verfasst von Maria Zanti und 59 weiteren Autor:innen. Beteiligte Einrichtung: Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus. Hauptthemen laut MEDLINE: BRCA2 Protein, Genetic Predisposition to Disease, BRCA1 Protein, Breast Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NCCDPHP CDC HHS, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A large number of variants identified through clinical genetic testing in disease susceptibility genes are of uncertain significance (VUS). Following the recommendations of the American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP), the frequency in case-control datasets (PS4 criterion) can inform their interpretation. We present a novel case-control likelihood ratio-based method that incorporates gene-specific age-related penetrance. We demonstrate the utility of this method in the analysis of simulated and real datasets. In the analysis of simulated data, the likelihood ratio method was more powerful compared to other methods. Likelihood ratios were calculated for a case-control dataset of BRCA1 and BRCA2 variants from the Breast Cancer Association Consortium (BCAC) and compared with logistic regression results. A larger number of variants reached evidence in favor of pathogenicity, and a substantial number of variants had evidence against pathogenicity—findings that would not have been reached using other case-control analysis methods. Our novel method provides greater power to classify rare variants compared with classical case-control methods. As an initiative from the ENIGMA Analytical Working Group, we provide user-friendly scripts and preformatted Excel calculators for implementation of the method for rare variants in BRCA1, BRCA2, and other high-risk genes with known penetrance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinGenetic Predisposition to DiseaseBRCA1 ProteinBreast NeoplasmsHumansCase-Control StudiesFemaleLikelihood FunctionsGenetic VariationPenetranceGenetic Testing

Stichwörter der Autor:innen

ACMG/AMPBRCAPS4VUScase-controllikelihood ratiovariant classification

Substanzen

BRCA2 ProteinBRCA1 ProteinBRCA1 protein, humanBRCA2 protein, human

Autor:innen und Institutionen

  • Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus.
  • Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  • Cancer Control and Population Science, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  • Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.
  • Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.

Förderung

  • NCI NIH HHS
  • NCCDPHP CDC HHS
  • Medical Research Council
  • NIEHS NIH HHS
  • Intramural NIH HHS
  • AECC
  • Fundación Mutua Madrileña
  • Autonomous Government of Galicia

Zitieren

APA

Zanti, M., O'Mahony, D. G., Parsons, M. T., Li, H., Dennis, J., Aittomäkkiki, K., Andrulis, I. L., Anton-Culver, H., Aronson, K. J., Augustinsson, A., Becher, H., Bojesen, S. E., Bolla, M. K., Brenner, H., Brown, M. A., Buys, S. S., Canzian, F., Caputo, S. M., Castelao, J. E., …, & John, E. M. (2023). A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2. Human Mutation. https://doi.org/10.1155/2023/9961341

Vancouver

Zanti M, O'Mahony DG, Parsons MT, Li H, Dennis J, Aittomäkkiki K, et al. A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2. Human Mutation. 2023. doi:10.1155/2023/9961341

BibTeX
@article{Zanti2023,
  author = {Zanti, Maria and O'Mahony, Denise G and Parsons, Michael T and Li, Hongyan and Dennis, Joe and Aittomäkkiki, Kristiina and Andrulis, Irene L and Anton-Culver, Hoda and Aronson, Kristan J and Augustinsson, Annelie and Becher, Heiko and Bojesen, Stig E and Bolla, Manjeet K and Brenner, Hermann and Brown, Melissa A and Buys, Saundra S and Canzian, Federico and Caputo, Sandrine M and Castelao, Jose E and Chang-Claude, Jenny and GC-HBOC study Collaborators, GC-HBOC study Collaborators and Czene, Kamila and Daly, Mary B and De Nicolo, Arcangela and Devilee, Peter and Dörk, Thilo and Dunning, Alison M and Dwek, Miriam and Eccles, Diana M and Engel, Christoph and Evans, D Gareth and Fasching, Peter A and Gago-Dominguez, Manuela and García-Closas, Montserrat and García-Sáenz, José A and Gentry-Maharaj, Aleksandra and Geurts-Giele, Willemina R R and Giles, Graham G and Glendon, Gord and Goldberg, Mark S and Garcia, Encarna B Gómez and Güendert, Melanie and Guénel, Pascal and Hahnen, Eric and Haiman, Christopher A and Hall, Per and Hamann, Ute and Harkness, Elaine F and Hogervorst, Frans B L and Hollestelle, Antoinette and Hoppe, Reiner and Hopper, John L and Houdayer, Claude and Houlston, Richard S and Howell, Anthony and ABCTB Investigators, ABCTB Investigators and Jakimovska, Milena and Jakubowska, Anna and Jernström, Helena and John, Esther M},
  title = {A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2},
  journal = {Human Mutation},
  year = {2023},
  doi = {10.1155/2023/9961341}
}
Kostenlos starten →